123 related articles for article (PubMed ID: 25638788)
1. Primary care management of early stage chronic lymphocytic leukaemia is safe and effective.
Parry HM; Damery S; Mudondo NP; Hazlewood P; McSkeane T; Aung S; Murray J; Pratt G; Moss P; Milligan DW
QJM; 2015 Oct; 108(10):789-94. PubMed ID: 25638788
[TBL] [Abstract][Full Text] [Related]
2. Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD).
Pfeil AM; Imfeld P; Pettengell R; Jick SS; Szucs TD; Meier CR; Schwenkglenks M
Ann Hematol; 2015 Mar; 94(3):421-9. PubMed ID: 25219890
[TBL] [Abstract][Full Text] [Related]
3. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes.
Parikh SA; Leis JF; Chaffee KG; Call TG; Hanson CA; Ding W; Chanan-Khan AA; Bowen D; Conte M; Schwager S; Slager SL; Van Dyke DL; Jelinek DF; Kay NE; Shanafelt TD
Cancer; 2015 Sep; 121(17):2883-91. PubMed ID: 25931291
[TBL] [Abstract][Full Text] [Related]
4. Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia.
Visentin A; Facco M; Frezzato F; Castelli M; Trimarco V; Martini V; Gattazzo C; Severin F; Chiodin G; Martines A; Bonaldi L; Gianesello I; Pagnin E; Boscaro E; Piazza F; Zambello R; Semenzato G; Trentin L
Clin Lymphoma Myeloma Leuk; 2015 Oct; 15(10):612-20.e1-5. PubMed ID: 26233718
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of ocular disease in chronic lymphocytic leukaemia.
Buchan J; McKibbin M; Burton T
Eye (Lond); 2003 Jan; 17(1):27-30. PubMed ID: 12579166
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic leukemia in Turkey: experience of a single center in Istanbul.
Pamuk ON; Pamuk GE; Soysal T; Ongören S; Başlar Z; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
South Med J; 2004 Mar; 97(3):240-5. PubMed ID: 15043330
[TBL] [Abstract][Full Text] [Related]
7. Limited value of routine follow-up visits in chronic lymphocytic leukemia managed initially by watch and wait: A North Denmark population-based study.
Nørgaard CH; Søgaard NB; Biccler JL; Pilgaard L; Eskesen MH; Kjartansdottir TH; Bøgsted M; El-Galaly TC
PLoS One; 2018; 13(12):e0208180. PubMed ID: 30589850
[TBL] [Abstract][Full Text] [Related]
8. Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study.
van Oers MH; Kuliczkowski K; Smolej L; Petrini M; Offner F; Grosicki S; Levin MD; Gupta I; Phillips J; Williams V; Manson S; Lisby S; Geisler C;
Lancet Oncol; 2015 Oct; 16(13):1370-9. PubMed ID: 26377300
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukaemia in the Bloemfontein academic hospitals.
Nel T; Joubert G; van der Ryst E; Bester I
Cent Afr J Med; 1998 Aug; 44(8):195-9. PubMed ID: 10101418
[TBL] [Abstract][Full Text] [Related]
10. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic leukaemia in Ethiopians.
Shamebo M; Gebremedhin A
East Afr Med J; 1996 Oct; 73(10):643-6. PubMed ID: 8997843
[TBL] [Abstract][Full Text] [Related]
12. Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005-2015 show improved survival over time.
Lindström V; Hakkarainen KM; Mehtälä J; Klement R; Leval A; Järvinen TM
Eur J Haematol; 2019 Sep; 103(3):190-199. PubMed ID: 31210368
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults.
Catovsky D; Fooks J; Richards S
Br J Haematol; 1989 Jun; 72(2):141-9. PubMed ID: 2757960
[TBL] [Abstract][Full Text] [Related]
14. Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia.
Richardson SE; Khan I; Rawstron A; Sudak J; Edwards N; Verfuerth S; Fielding AK; Goldstone A; Kottaridis P; Morris E; Benjamin R; Peggs KS; Thomson KJ; Vandenberghe E; Mackinnon S; Chakraverty R
Br J Haematol; 2013 Mar; 160(5):640-8. PubMed ID: 23293871
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factor analysis in 203 patients with chronic lymphocytic leukaemia].
Wu T; Li ZJ; Wang YF; Zhao YZ; Qi JY; Qian LS; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2009 Jul; 30(7):435-9. PubMed ID: 19954591
[TBL] [Abstract][Full Text] [Related]
16. South Asian chronic lymphocytic leukaemia patients have more rapid disease progression in comparison to White patients.
Gunawardana C; Austen B; Powell JE; Fegan C; Wandroo F; Jacobs A; Pratt G; Moss P
Br J Haematol; 2008 Aug; 142(4):606-9. PubMed ID: 18503582
[TBL] [Abstract][Full Text] [Related]
17. Higher percentage of in vitro apoptotic cells at time of diagnosis in patients with chronic lymphocytic leukemia indicate earlier treatment requirement: ten years follow up.
Kravić-Stevović T; Bogdanović A; Bumbasirević V
Srp Arh Celok Lek; 2014; 142(1-2):48-53. PubMed ID: 24684031
[TBL] [Abstract][Full Text] [Related]
18. What is changing in the natural history of chronic lymphocytic leukemia?
Molica S; Levato D
Haematologica; 2001 Jan; 86(1):8-12. PubMed ID: 11146563
[TBL] [Abstract][Full Text] [Related]
19. Disease burden of chronic lymphocytic leukaemia within the European Union.
Watson L; Wyld P; Catovsky D
Eur J Haematol; 2008 Oct; 81(4):253-8. PubMed ID: 18616512
[TBL] [Abstract][Full Text] [Related]
20. The clinical course of lung carcinoma in patients with chronic lymphocytic leukemia.
Parekh K; Rusch V; Kris M
Cancer; 1999 Nov; 86(9):1720-3. PubMed ID: 10547544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
